CLD-101 is a novel stem cell-based treatment that delivers oncolytic viruses to tumors, which may benefit patients with newly ...

Ninlaro, Thalomid and dexamethasone followed by Ninlarlo maintenance may improve durability of response in myeloma after stem ...

Martha Carlson shares her experience of overcoming her fears and embarking on a whitewater rafting adventure despite her ...

A study found that nearly all older patients with ER-positive DCIS could have avoided lymph node removal, researchers have ...

CURE partnered with SHARE Cancer Support to learn more about the importance of emotional well-being and a strong support ...

More than 60% of patients with relapsed or refractory KMT2Ar acute leukemia responded to the menin inhibitor revumenib.

This trial is assessing CBX-12 as a potential treatment for ovarian cancer, with additional studies to be conducted in other ...

Call to Action: Proposed FDA Regulations Could Limit Cancer Patient Access to Life-Saving Therapies ...

Among patients with Merkel cell carcinoma, using ctDNA testing may help with watching the disease for potential recurrences ...

Cancer is complicated, especially with multiple diagnoses, oncologists, tests and integrative treatments, but AI can be a ...

Lazcluze demonstrated significant CNS activity, regardless of T790M status, in treating intracranial and leptomeningeal ...

For patients with adenocarcinoma of the esophagus and esophagogastric junction, chemoradiotherapy and chemotherapy improved ...